Pharmaceutical Manufacturing Market Size, Share & Growth Graph by 2034

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Pharmaceutical Manufacturing Market Size Analysis

Global Pharmaceutical Manufacturing Market Introduction
By Drug Development Type
1. Introduction
  1. Drug Development Type By Value
2. Outsource
  1. By Value
3. In-house
  1. By Value
By Formulation
1. Introduction
  1. Formulation By Value
2. Tablets
  1. By Value
3. Capsules
  1. By Value
4. Injectable
  1. By Value
5. Sprays
  1. By Value
6. Suspensions
  1. By Value
7. Powders
  1. By Value
8. Other Formulations
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral
  1. By Value
3. Topical
  1. By Value
4. Parenteral
  1. By Value
5. Inhalations
  1. By Value
6. Other Routes of Administration
  1. By Value
By Therapy Area
1. Introduction
  1. Therapy Area By Value
2. Cardiovascular Diseases
  1. By Value
3. Pain
  1. By Value
4. Cancer
  1. By Value
5. Respiratory Diseases
  1. By Value
6. Other Diseases
  1. By Value
By Prescription
1. Introduction
  1. Prescription By Value
2. Prescription Medicines
  1. By Value
3. Over-the-counter (OTC) Medicines
  1. By Value
By Age Type
1. Introduction
  1. Age Type By Value
2. Children & Adolescents
  1. By Value
3. Adults
  1. By Value
4. Geriatric
  1. By Value
By Sales Channel
1. Introduction
  1. Sales Channel By Value
2. Retail
  1. By Value
3. Non-retail
  1. By Value

North America Market Analysis

Introduction
By Drug Development Type
1. Introduction
  1. Drug Development Type By Value
2. Outsource
  1. By Value
3. In-house
  1. By Value
By Formulation
1. Introduction
  1. Formulation By Value
2. Tablets
  1. By Value
3. Capsules
  1. By Value
4. Injectable
  1. By Value
5. Sprays
  1. By Value
6. Suspensions
  1. By Value
7. Powders
  1. By Value
8. Other Formulations
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral
  1. By Value
3. Topical
  1. By Value
4. Parenteral
  1. By Value
5. Inhalations
  1. By Value
6. Other Routes of Administration
  1. By Value
By Therapy Area
1. Introduction
  1. Therapy Area By Value
2. Cardiovascular Diseases
  1. By Value
3. Pain
  1. By Value
4. Cancer
  1. By Value
5. Respiratory Diseases
  1. By Value
6. Other Diseases
  1. By Value
By Prescription
1. Introduction
  1. Prescription By Value
2. Prescription Medicines
  1. By Value
3. Over-the-counter (OTC) Medicines
  1. By Value
By Age Type
1. Introduction
  1. Age Type By Value
2. Children & Adolescents
  1. By Value
3. Adults
  1. By Value
4. Geriatric
  1. By Value
By Sales Channel
1. Introduction
  1. Sales Channel By Value
2. Retail
  1. By Value
3. Non-retail
  1. By Value
U.S.
1. By Drug Development Type
  1. Introduction
    1. Drug Development Type By Value
  2. Outsource
    1. By Value
  3. In-house
    1. By Value
2. By Formulation
  1. Introduction
    1. Formulation By Value
  2. Tablets
    1. By Value
  3. Capsules
    1. By Value
  4. Injectable
    1. By Value
  5. Sprays
    1. By Value
  6. Suspensions
    1. By Value
  7. Powders
    1. By Value
  8. Other Formulations
    1. By Value
3. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Oral
    1. By Value
  3. Topical
    1. By Value
  4. Parenteral
    1. By Value
  5. Inhalations
    1. By Value
  6. Other Routes of Administration
    1. By Value
4. By Therapy Area
  1. Introduction
    1. Therapy Area By Value
  2. Cardiovascular Diseases
    1. By Value
  3. Pain
    1. By Value
  4. Cancer
    1. By Value
  5. Respiratory Diseases
    1. By Value
  6. Other Diseases
    1. By Value
5. By Prescription
  1. Introduction
    1. Prescription By Value
  2. Prescription Medicines
    1. By Value
  3. Over-the-counter (OTC) Medicines
    1. By Value
6. By Age Type
  1. Introduction
    1. Age Type By Value
  2. Children & Adolescents
    1. By Value
  3. Adults
    1. By Value
  4. Geriatric
    1. By Value
7. By Sales Channel
  1. Introduction
    1. Sales Channel By Value
  2. Retail
    1. By Value
  3. Non-retail
    1. By Value
Canada

Europe Market Analysis

Introduction
By Drug Development Type
1. Introduction
  1. Drug Development Type By Value
2. Outsource
  1. By Value
3. In-house
  1. By Value
By Formulation
1. Introduction
  1. Formulation By Value
2. Tablets
  1. By Value
3. Capsules
  1. By Value
4. Injectable
  1. By Value
5. Sprays
  1. By Value
6. Suspensions
  1. By Value
7. Powders
  1. By Value
8. Other Formulations
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral
  1. By Value
3. Topical
  1. By Value
4. Parenteral
  1. By Value
5. Inhalations
  1. By Value
6. Other Routes of Administration
  1. By Value
By Therapy Area
1. Introduction
  1. Therapy Area By Value
2. Cardiovascular Diseases
  1. By Value
3. Pain
  1. By Value
4. Cancer
  1. By Value
5. Respiratory Diseases
  1. By Value
6. Other Diseases
  1. By Value
By Prescription
1. Introduction
  1. Prescription By Value
2. Prescription Medicines
  1. By Value
3. Over-the-counter (OTC) Medicines
  1. By Value
By Age Type
1. Introduction
  1. Age Type By Value
2. Children & Adolescents
  1. By Value
3. Adults
  1. By Value
4. Geriatric
  1. By Value
By Sales Channel
1. Introduction
  1. Sales Channel By Value
2. Retail
  1. By Value
3. Non-retail
  1. By Value
U.K.
1. By Drug Development Type
  1. Introduction
    1. Drug Development Type By Value
  2. Outsource
    1. By Value
  3. In-house
    1. By Value
2. By Formulation
  1. Introduction
    1. Formulation By Value
  2. Tablets
    1. By Value
  3. Capsules
    1. By Value
  4. Injectable
    1. By Value
  5. Sprays
    1. By Value
  6. Suspensions
    1. By Value
  7. Powders
    1. By Value
  8. Other Formulations
    1. By Value
3. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Oral
    1. By Value
  3. Topical
    1. By Value
  4. Parenteral
    1. By Value
  5. Inhalations
    1. By Value
  6. Other Routes of Administration
    1. By Value
4. By Therapy Area
  1. Introduction
    1. Therapy Area By Value
  2. Cardiovascular Diseases
    1. By Value
  3. Pain
    1. By Value
  4. Cancer
    1. By Value
  5. Respiratory Diseases
    1. By Value
  6. Other Diseases
    1. By Value
5. By Prescription
  1. Introduction
    1. Prescription By Value
  2. Prescription Medicines
    1. By Value
  3. Over-the-counter (OTC) Medicines
    1. By Value
6. By Age Type
  1. Introduction
    1. Age Type By Value
  2. Children & Adolescents
    1. By Value
  3. Adults
    1. By Value
  4. Geriatric
    1. By Value
7. By Sales Channel
  1. Introduction
    1. Sales Channel By Value
  2. Retail
    1. By Value
  3. Non-retail
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Drug Development Type
1. Introduction
  1. Drug Development Type By Value
2. Outsource
  1. By Value
3. In-house
  1. By Value
By Formulation
1. Introduction
  1. Formulation By Value
2. Tablets
  1. By Value
3. Capsules
  1. By Value
4. Injectable
  1. By Value
5. Sprays
  1. By Value
6. Suspensions
  1. By Value
7. Powders
  1. By Value
8. Other Formulations
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral
  1. By Value
3. Topical
  1. By Value
4. Parenteral
  1. By Value
5. Inhalations
  1. By Value
6. Other Routes of Administration
  1. By Value
By Therapy Area
1. Introduction
  1. Therapy Area By Value
2. Cardiovascular Diseases
  1. By Value
3. Pain
  1. By Value
4. Cancer
  1. By Value
5. Respiratory Diseases
  1. By Value
6. Other Diseases
  1. By Value
By Prescription
1. Introduction
  1. Prescription By Value
2. Prescription Medicines
  1. By Value
3. Over-the-counter (OTC) Medicines
  1. By Value
By Age Type
1. Introduction
  1. Age Type By Value
2. Children & Adolescents
  1. By Value
3. Adults
  1. By Value
4. Geriatric
  1. By Value
By Sales Channel
1. Introduction
  1. Sales Channel By Value
2. Retail
  1. By Value
3. Non-retail
  1. By Value
China
1. By Drug Development Type
  1. Introduction
    1. Drug Development Type By Value
  2. Outsource
    1. By Value
  3. In-house
    1. By Value
2. By Formulation
  1. Introduction
    1. Formulation By Value
  2. Tablets
    1. By Value
  3. Capsules
    1. By Value
  4. Injectable
    1. By Value
  5. Sprays
    1. By Value
  6. Suspensions
    1. By Value
  7. Powders
    1. By Value
  8. Other Formulations
    1. By Value
3. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Oral
    1. By Value
  3. Topical
    1. By Value
  4. Parenteral
    1. By Value
  5. Inhalations
    1. By Value
  6. Other Routes of Administration
    1. By Value
4. By Therapy Area
  1. Introduction
    1. Therapy Area By Value
  2. Cardiovascular Diseases
    1. By Value
  3. Pain
    1. By Value
  4. Cancer
    1. By Value
  5. Respiratory Diseases
    1. By Value
  6. Other Diseases
    1. By Value
5. By Prescription
  1. Introduction
    1. Prescription By Value
  2. Prescription Medicines
    1. By Value
  3. Over-the-counter (OTC) Medicines
    1. By Value
6. By Age Type
  1. Introduction
    1. Age Type By Value
  2. Children & Adolescents
    1. By Value
  3. Adults
    1. By Value
  4. Geriatric
    1. By Value
7. By Sales Channel
  1. Introduction
    1. Sales Channel By Value
  2. Retail
    1. By Value
  3. Non-retail
    1. By Value
Korea
Japan
India
Australia
Singapore
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Drug Development Type
1. Introduction
  1. Drug Development Type By Value
2. Outsource
  1. By Value
3. In-house
  1. By Value
By Formulation
1. Introduction
  1. Formulation By Value
2. Tablets
  1. By Value
3. Capsules
  1. By Value
4. Injectable
  1. By Value
5. Sprays
  1. By Value
6. Suspensions
  1. By Value
7. Powders
  1. By Value
8. Other Formulations
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral
  1. By Value
3. Topical
  1. By Value
4. Parenteral
  1. By Value
5. Inhalations
  1. By Value
6. Other Routes of Administration
  1. By Value
By Therapy Area
1. Introduction
  1. Therapy Area By Value
2. Cardiovascular Diseases
  1. By Value
3. Pain
  1. By Value
4. Cancer
  1. By Value
5. Respiratory Diseases
  1. By Value
6. Other Diseases
  1. By Value
By Prescription
1. Introduction
  1. Prescription By Value
2. Prescription Medicines
  1. By Value
3. Over-the-counter (OTC) Medicines
  1. By Value
By Age Type
1. Introduction
  1. Age Type By Value
2. Children & Adolescents
  1. By Value
3. Adults
  1. By Value
4. Geriatric
  1. By Value
By Sales Channel
1. Introduction
  1. Sales Channel By Value
2. Retail
  1. By Value
3. Non-retail
  1. By Value
UAE
1. By Drug Development Type
  1. Introduction
    1. Drug Development Type By Value
  2. Outsource
    1. By Value
  3. In-house
    1. By Value
2. By Formulation
  1. Introduction
    1. Formulation By Value
  2. Tablets
    1. By Value
  3. Capsules
    1. By Value
  4. Injectable
    1. By Value
  5. Sprays
    1. By Value
  6. Suspensions
    1. By Value
  7. Powders
    1. By Value
  8. Other Formulations
    1. By Value
3. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Oral
    1. By Value
  3. Topical
    1. By Value
  4. Parenteral
    1. By Value
  5. Inhalations
    1. By Value
  6. Other Routes of Administration
    1. By Value
4. By Therapy Area
  1. Introduction
    1. Therapy Area By Value
  2. Cardiovascular Diseases
    1. By Value
  3. Pain
    1. By Value
  4. Cancer
    1. By Value
  5. Respiratory Diseases
    1. By Value
  6. Other Diseases
    1. By Value
5. By Prescription
  1. Introduction
    1. Prescription By Value
  2. Prescription Medicines
    1. By Value
  3. Over-the-counter (OTC) Medicines
    1. By Value
6. By Age Type
  1. Introduction
    1. Age Type By Value
  2. Children & Adolescents
    1. By Value
  3. Adults
    1. By Value
  4. Geriatric
    1. By Value
7. By Sales Channel
  1. Introduction
    1. Sales Channel By Value
  2. Retail
    1. By Value
  3. Non-retail
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Drug Development Type
1. Introduction
  1. Drug Development Type By Value
2. Outsource
  1. By Value
3. In-house
  1. By Value
By Formulation
1. Introduction
  1. Formulation By Value
2. Tablets
  1. By Value
3. Capsules
  1. By Value
4. Injectable
  1. By Value
5. Sprays
  1. By Value
6. Suspensions
  1. By Value
7. Powders
  1. By Value
8. Other Formulations
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral
  1. By Value
3. Topical
  1. By Value
4. Parenteral
  1. By Value
5. Inhalations
  1. By Value
6. Other Routes of Administration
  1. By Value
By Therapy Area
1. Introduction
  1. Therapy Area By Value
2. Cardiovascular Diseases
  1. By Value
3. Pain
  1. By Value
4. Cancer
  1. By Value
5. Respiratory Diseases
  1. By Value
6. Other Diseases
  1. By Value
By Prescription
1. Introduction
  1. Prescription By Value
2. Prescription Medicines
  1. By Value
3. Over-the-counter (OTC) Medicines
  1. By Value
By Age Type
1. Introduction
  1. Age Type By Value
2. Children & Adolescents
  1. By Value
3. Adults
  1. By Value
4. Geriatric
  1. By Value
By Sales Channel
1. Introduction
  1. Sales Channel By Value
2. Retail
  1. By Value
3. Non-retail
  1. By Value
Brazil
1. By Drug Development Type
  1. Introduction
    1. Drug Development Type By Value
  2. Outsource
    1. By Value
  3. In-house
    1. By Value
2. By Formulation
  1. Introduction
    1. Formulation By Value
  2. Tablets
    1. By Value
  3. Capsules
    1. By Value
  4. Injectable
    1. By Value
  5. Sprays
    1. By Value
  6. Suspensions
    1. By Value
  7. Powders
    1. By Value
  8. Other Formulations
    1. By Value
3. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Oral
    1. By Value
  3. Topical
    1. By Value
  4. Parenteral
    1. By Value
  5. Inhalations
    1. By Value
  6. Other Routes of Administration
    1. By Value
4. By Therapy Area
  1. Introduction
    1. Therapy Area By Value
  2. Cardiovascular Diseases
    1. By Value
  3. Pain
    1. By Value
  4. Cancer
    1. By Value
  5. Respiratory Diseases
    1. By Value
  6. Other Diseases
    1. By Value
5. By Prescription
  1. Introduction
    1. Prescription By Value
  2. Prescription Medicines
    1. By Value
  3. Over-the-counter (OTC) Medicines
    1. By Value
6. By Age Type
  1. Introduction
    1. Age Type By Value
  2. Children & Adolescents
    1. By Value
  3. Adults
    1. By Value
  4. Geriatric
    1. By Value
7. By Sales Channel
  1. Introduction
    1. Sales Channel By Value
  2. Retail
    1. By Value
  3. Non-retail
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Pharmaceutical Manufacturing Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Hovione
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
SK pharmteco
Samsung Biologics
SK Capital Partners
Lonza
Hoffmann-La Roche Ltd.
Novartis AG
GlaxoSmithKline plc
Pfizer, Inc.
Merck & Co., Inc.
AstraZeneca
Johnson & Johnson
Sanofi SA
Eli Lilly and Company
AbbVie, Inc.
Thermo Fisher Scientific, Inc.
Wuxi Apptec
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
Catalent Pharma Solutions
Jubilant Pharmova Limited

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment

Appendix

Discussion Guide
Customization Options
Related Reports

Disclaimer

Get This Report

Our Clients:

Hindustan National Glass & Industries Limited

Table Of Content

Download Free Sample

Mitiksha Koul

Research Associate